Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 9.241\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a. O=C(NC1CC1)c1cccc(Br)c1
b. CCN(CC)S(=O)(=O)c1ccc(NC(=O)c2cccs2)cc1
c. Cc1nc(N2CCOCC2)nc(N2CCCCC2C)c1[N+](=O)[O-]
d. Nc1nc(CSc2nnc(-c3cccc(F)c3)n2-c2ccccc2)nc(N2CCOCC2)n1
Answer: c. Cc1nc(N2CCOCC2)nc(N2CCCCC2C)c1[N+](=O)[O-]
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nc(N2CCOCC2)nc(N2CCCCC2C)c1[N+](=O)[O-]
Cc1nc(N2CCOCC2)nc(N2CCCCC2C)c1[N+](=O)[O-]
4-[4-methyl-6-(2-methylpiperidin-1-yl)-5-nitropyrimidin-2-yl]morpholine